Invention Grant
- Patent Title: Quinoxaline derivatives as adenosine receptor antagonists
-
Application No.: US16640526Application Date: 2018-08-20
-
Publication No.: US11192899B2Publication Date: 2021-12-07
- Inventor: Eva-Maria Tanzer , Kai Schiemann , Markus Klein
- Applicant: MERCK PATENT GMBH
- Applicant Address: DE Darmstadt
- Assignee: MERCK PATENT GMBH
- Current Assignee: MERCK PATENT GMBH
- Current Assignee Address: DE Darmstadt
- Agency: Millen White Zelano and Branigan, PC
- Agent Csaba Henter
- Priority: EP17187100 20170821
- International Application: PCT/EP2018/072397 WO 20180820
- International Announcement: WO2019/038214 WO 20190228
- Main IPC: C07D495/10
- IPC: C07D495/10 ; C07D241/44 ; C07D401/12 ; C07D403/04 ; C07D413/14 ; C07D405/14 ; C07D405/04 ; C07D471/04 ; C07D491/107 ; C07D417/12 ; C07D403/12 ; A61K45/06
Abstract:
The invention relates to quinoxaline derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
Information query
